davita inc. - DVA

DVA

Close Chg Chg %
153.21 1.87 1.22%

Pre-Market

155.08

+1.87 (1.22%)

Volume: 539.38K

Last Updated:

Mar 25, 2026, 3:59 PM EDT

Company Overview: davita inc. - DVA

DVA Key Data

Open

$153.99

Day Range

152.06 - 155.61

52 Week Range

101.00 - 159.39

Market Cap

$10.24B

Shares Outstanding

66.80M

Public Float

63.18M

Beta

0.93

Rev. Per Employee

N/A

P/E Ratio

16.11

EPS

$9.77

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

946.90K

 

DVA Performance

1 Week
 
2.66%
 
1 Month
 
-1.93%
 
3 Months
 
34.48%
 
1 Year
 
2.04%
 
5 Years
 
40.92%
 

DVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About davita inc. - DVA

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DVA At a Glance

DaVita, Inc.
2000 16th Street
Denver, Colorado 80202-7198
Phone 1-720-631-2100 Revenue 13.64B
Industry Medical/Nursing Services Net Income 721.80M
Sector Health Services 2025 Sales Growth 6.457%
Fiscal Year-end 12 / 2026 Employees 78,000
View SEC Filings

DVA Valuation

P/E Current 16.002
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.944
Price to Sales Ratio 0.632
Price to Book Ratio N/A
Price to Cash Flow Ratio 4.57
Enterprise Value to EBITDA 8.336
Enterprise Value to Sales 1.666
Total Debt to Enterprise Value 0.575

DVA Efficiency

Revenue/Employee 174,911.141
Income Per Employee 9,253.885
Receivables Turnover 4.611
Total Asset Turnover 0.756

DVA Liquidity

Current Ratio 1.292
Quick Ratio 1.241
Cash Ratio 0.249

DVA Profitability

Gross Margin 27.005
Operating Margin 14.737
Pretax Margin 9.872
Net Margin 5.291
Return on Assets 4.001
Return on Equity N/A
Return on Total Capital 5.81
Return on Invested Capital 6.224

DVA Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 105.241
Total Debt to Total Assets 72.198
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 99.328
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Davita Inc. - DVA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
11.61B 12.14B 12.82B 13.64B
Sales Growth
-0.08% +4.57% +5.56% +6.46%
Cost of Goods Sold (COGS) incl D&A
8.94B 9.07B 9.32B 9.96B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
732.60M 745.44M 723.86M 715.35M
Depreciation
721.13M 736.47M 716.40M 708.25M
Amortization of Intangibles
11.47M 8.97M 7.46M 7.10M
COGS Growth
+3.34% +1.38% +2.84% +6.83%
Gross Income
2.67B 3.07B 3.49B 3.68B
Gross Income Growth
-10.05% +15.27% +13.60% +5.47%
Gross Profit Margin
+22.98% +25.33% +27.26% +27.00%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.36B 1.47B 1.54B 1.67B
Research & Development
- - - -
-
Other SG&A
1.36B 1.47B 1.54B 1.67B
SGA Growth
+13.37% +8.77% +4.37% +8.79%
Other Operating Expense
- - - -
-
Unusual Expense
(5.92M) 22.88M (89.65M) 14.18M
EBIT after Unusual Expense
1.32B 1.58B 2.04B 2.00B
Non Operating Income/Expense
(6.90M) (106.05M) (101.79M) (59.72M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
26.52M 27.86M 26.19M 33.00M
Interest Expense
345.29M 294.98M 412.29M 589.89M
Interest Expense Growth
+23.43% -14.57% +39.77% +43.08%
Gross Interest Expense
357.96M 304.16M 420.27M 589.89M
Interest Capitalized
- 12.68M 9.18M 7.98M
Pretax Income
966.28M 1.18B 1.53B 1.35B
Pretax Income Growth
-36.37% +21.82% +30.01% -11.99%
Pretax Margin
+8.32% +9.70% +11.94% +9.87%
Income Tax
198.09M 220.12M 279.66M 293.11M
Income Tax - Current - Domestic
257.52M 238.44M 305.91M 161.20M
Income Tax - Current - Foreign
16.25M 21.01M 31.53M 45.34M
Income Tax - Deferred - Domestic
(78.69M) (39.87M) (50.57M) 87.73M
Income Tax - Deferred - Foreign
3.00M 535.00K (7.22M) (1.16M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
26.52M 27.86M 26.19M 33.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
768.19M 956.98M 1.25B 1.05B
Minority Interest Expense
221.24M 265.44M 314.39M 331.91M
Net Income
546.95M 691.53M 936.34M 721.80M
Net Income Growth
-44.10% +26.44% +35.40% -22.91%
Net Margin Growth
+4.71% +5.70% +7.31% +5.29%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
546.95M 691.53M 936.34M 721.80M
Preferred Dividends
- - - -
-
Net Income Available to Common
546.95M 691.53M 936.34M 721.80M
EPS (Basic)
5.8817 7.6169 11.017 9.7243
EPS (Basic) Growth
-36.74% +29.50% +44.64% -11.73%
Basic Shares Outstanding
92.99M 90.79M 84.99M 74.23M
EPS (Diluted)
5.7072 7.4213 10.7288 9.5118
EPS (Diluted) Growth
-35.87% +30.03% +44.57% -11.34%
Diluted Shares Outstanding
95.83M 93.18M 87.27M 75.89M
EBITDA
2.05B 2.35B 2.68B 2.73B
EBITDA Growth
-16.56% +14.73% +14.16% +1.76%
EBITDA Margin
+17.62% +19.33% +20.90% +19.98%

Snapshot

Average Recommendation HOLD Average Target Price 146.00
Number of Ratings 11 Current Quarters Estimate 2.319
FY Report Date 03 / 2026 Current Year's Estimate 14.132
Last Quarter’s Earnings 3.40 Median PE on CY Estimate N/A
Year Ago Earnings 10.78 Next Fiscal Year Estimate 16.271
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 7 7
Mean Estimate 2.32 3.66 14.13 16.27
High Estimates 2.46 4.03 14.36 17.16
Low Estimate 2.22 3.43 13.83 15.37
Coefficient of Variance 3.87 6.31 1.49 4.43

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 1 1 1
HOLD 7 7 9
UNDERWEIGHT 2 2 1
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Davita Inc. - DVA

Date Name Shares Transaction Value
Mar 13, 2026 Joel Ackerman CFO and Treasurer 155,022 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 13, 2026 Joel Ackerman CFO and Treasurer 221,019 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 13, 2026 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 103,947 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 13, 2026 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 155,277 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 13, 2026 James O. Hearty Chief Compliance Officer 28,054 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 13, 2026 James O. Hearty Chief Compliance Officer 48,587 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Davita Inc. in the News